Abstract
Background: Botulinum toxin type A (BoNT-A) has become the treatment of choice for most types of focal dystonia. Objective: To investigate the efficacy of BoNT-A injections in patients with writer’s...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have